← All trials
NCT00676975
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 26, 2008
- Primary completion
- Dec 30, 2010
- Completion date
- Aug 30, 2011
- First posted
- May 13, 2008
- Last posted
- Apr 25, 2017
- Enrollment
- 104
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Chinese University of Hong KongLead sponsor
- Chinese University of Hong KongOverall official - principal investigator
- Chinese University of Hong KongReponsible party - principal investigator
- National Center for Complementary and Integrative Health (NCCIH)Collaborator
- University of MarylandCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.